Visual laser ablation of the prostate [VLAP] with bare fiber in conjunction with laser bladder neck incision in the treatment of patients with benign prostatic hyperplasia [BPH]

The objective of this paper was to assess the effectiveness of visual laser ablation of the prostate [VLAP] using a bare fiber with simultaneous laser incision of the bladder neck for patients with symptomatic benign prostatic hyperplasia. Sixty-seven patients with symptomatic bladder outlet obstruction due to benign prostatic hyperplasia were entered into a prospective trial where VLAP was done with neodymium: YAG laser, while the bladder neck incision was done with KTP laser was delivered using a bare fiber. There was marked improvement demonstrated at three months post-lasing in symptom score and flow rate. No significant changes were noticed in the subsequent follow-up. However, the bladder neck incision increased the rate of retrograde ejaculation without appreciable improvement in symptom score or flow rate when compared to other published data. None of the patients developed bladder neck contracture. VLAP, using a bare fiber, in conjunction with laser bladder neck incision, produces durable improvement in urine flow rate and symptom score in patients with symptomatic benign prostatic hyperplasia without the development of bladder neck contracturer. This method will reduce the costs of laser prostatectomy

Evaluation of a symptom score index for measurement of lower urinary symptoms in arabic form

To evaluate an Arabic translation of a score index for measuring the severity of symptoms produced by benign prostatic hypertrophy [BPH]. A prospective study on 84 subjects. We first translated the symptom score index from its original English-American language; this questionnaire was then given to patients to be self-administered, as intended by the American Urological Association [AUA]. Assistance by a relative or guidance from the managing physician was allowed when required. The Arabic symptom score index was evaluated by [1] the ability of patients to understand the questions; [2] the ability of patients to complete the answers; [3] test/retesting the same patients' symptoms after a short period of time [1 week]; and [4] any change in the score following treatment Our results indicate the usefulness of the symptom score index in Arabic for assessing patients with symptoms produced by BPH. An objective method of measuring these symptoms is now available for Arabic-speaking patients. Conclusion: The assessment of symptoms by a score index system has become standard medical policy and the Arabic translation should be used in the management of BPH in all Arabic-speaking patients